<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114435">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02071667</url>
  </required_header>
  <id_info>
    <org_study_id>17123</org_study_id>
    <nct_id>NCT02071667</nct_id>
  </id_info>
  <brief_title>Association of Periostin Levels and Chronic Sinusitis</brief_title>
  <official_title>Association of Periostin Levels and Chronic Sinusitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if a protein in blood, called periostin, can determine
      if patients have chronic sinusitis.  This protein is in everyone's body, but the level of
      the protein may indicate certain conditions such as chronic sinusitis.   The investigators
      are interested in testing levels of periostin to see if they are higher or lower than
      patients without chronic sinusitis, just as periostin is higher in patients with asthma.
      All patients enrolled in this study will have chronic sinusitis without asthma.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Difference in circulating serum periostin levels pre and post sinus surgery</measure>
    <time_frame>10-15 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Serum collected prior to and following sinus surgery will be analyzed for concentrations of the protein periostin.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Sinusitis</condition>
  <condition>Nasal Polyps</condition>
  <arm_group>
    <arm_group_label>Subjects who require sinus surgery</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood draw</intervention_name>
    <arm_group_label>Subjects who require sinus surgery</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and paraffin embedded nasal polyp tissue samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who are recommended for sinus surgery as part of their care who self report no
        asthma.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with sinus disease which requires surgical intervention

          -  Ability to understand and give informed consent

        Exclusion Criteria:

          -  Previous diagnosis of asthma

          -  Positive methacholine challenge at screening

          -  Diagnosis of cystic fibrosis

          -  Concomitant use of systemic corticosteroids (except for those prescribed as part of
             standard pre-surgical treatment)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>John Steinke</last_name>
    <phone>434-982-3270</phone>
    <email>js3ch@virginia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>John Steinke</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 21, 2014</lastchanged_date>
  <firstreceived_date>February 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>John Steinke</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Chronic sinusitis</keyword>
  <keyword>Nasal Polyps</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nasal Polyps</mesh_term>
    <mesh_term>Polyps</mesh_term>
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
